Cargando…
Metronomic palliative chemotherapy in maxillary sinus tumor
BACKGROUND: Metronomic chemotherapy consisting of methotrexate and celecoxib recently has shown promising results in multiple studies in head and neck cancers. However, these studies have not included patients with maxillary sinus primaries. Hence, the role of palliative metronomic chemotherapy in p...
Autores principales: | Patil, Vijay M., Noronh, Vanita, Joshi, Amit, Karpe, Ashay, Talreja, Vikas, Chandrasekharan, Arun, Dhumal, Sachin, Prabhash, Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873696/ https://www.ncbi.nlm.nih.gov/pubmed/27275447 http://dx.doi.org/10.4103/2278-330X.181626 |
Ejemplares similares
-
Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer
por: Noronha, Vanita, et al.
Publicado: (2016) -
Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patients
por: Patil, Vijay, et al.
Publicado: (2018) -
Palliative chemotherapy in carcinoma nasopharynx
por: Patil, Vijay M., et al.
Publicado: (2019) -
Outcome of operable oral cavity cancer and impact of maintenance metronomic chemotherapy: A retrospective study from rural India
por: Pandey, Avinash, et al.
Publicado: (2016) -
An audit of the results of a triplet metronomic chemotherapy regimen incorporating a tyrosine kinase inhibitor in recurrent/metastatic head and neck cancers patients
por: Patil, Vijay M., et al.
Publicado: (2016)